Cue Biopharma, Inc. (CUE) at a glance

Cue Biopharma, Inc. (CUE) is a micro-cap Healthcare company. It trades at $26.89, with a -59.6% profit margin and revenue growth of 1250.6%. It does not pay a dividend. Vestovix scores it 56/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Value (40/100).

Price
$26.89
Market cap
$103.0M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$4.98 to $45.50
Vestovix Score56/ 100How this works
Value
40
Growth
94
Income
40
Safety
46
Momentum
53

Other Healthcare stocks

See all